+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Discovery AI Tools Market - Global Forecast 2026-2032- Product Image
Drug Discovery AI Tools Market - Global Forecast 2026-2032- Product Image
Sale

Drug Discovery AI Tools Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6278584
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Drug Discovery AI Tools: Executive Summary and Strategic Context

Drug discovery AI tools apply machine learning, deep learning, generative models, knowledge graphs, and related analytical methods to activities such as target identification, hit discovery, molecular design, biomarker analysis, and preclinical decision-making. Their strategic importance lies in helping research teams process complex biological and chemical data, prioritize experiments, and connect evidence across previously fragmented workflows. Adoption remains shaped by data quality, model interpretability, laboratory validation, regulatory expectations, intellectual-property considerations, and the ability to integrate tools into established research environments.

How AI Is Reshaping Drug Discovery Workflows

The landscape is shifting from isolated computational experiments toward connected workflows that combine literature mining, omics analysis, structure-based design, virtual screening, synthesis planning, and experimental feedback. This transformation increases the value of interoperable data systems and reproducible pipelines rather than standalone algorithms. At the same time, organizations are placing greater emphasis on traceability, human review, prospective validation, and carefully defined performance criteria, reflecting the high cost of false positives and the scientific consequences of unreliable predictions.

Artificial Intelligence’s Cumulative Impact Across the R&D Chain

Artificial intelligence can influence multiple stages of discovery simultaneously: identifying biological relationships, ranking targets, proposing molecular structures, predicting properties, and supporting the design of experiments. The cumulative effect is strongest when models are linked to high-quality data and iterative laboratory testing, allowing experimental results to refine subsequent computational decisions. Benefits are constrained when datasets are sparse, biased, poorly annotated, or disconnected from operational systems. Consequently, AI should be treated as a decision-support capability whose value depends on scientific governance, validation, and integration with medicinal-chemistry and biology expertise.

Regional Insights: Uneven Adoption Shaped by Research Capacity and Regulation

North America benefits from deep pharmaceutical, biotechnology, academic, and technology ecosystems, while also maintaining strong attention to data governance and translational validation. Europe combines substantial public research capacity with stringent privacy, medical, and AI governance considerations; collaboration across the European Union remains important for data and regulatory alignment. Asia-Pacific is supported by expanding computational biology capabilities, advanced manufacturing and research infrastructure in several economies, and growing interest in national life-sciences strategies. Latin America is developing capabilities through universities, public institutions, and partnerships, although access to specialized data, infrastructure, and funding varies. The Middle East is investing in digital research capacity and innovation infrastructure, while the African market is characterized by emerging research networks, public-health priorities, and a need for sustained skills, connectivity, and locally relevant datasets.

Group Insights: Collaboration and Policy Shape Collective Capability

ASEAN countries show varied levels of digital infrastructure and biomedical research maturity, making regional knowledge exchange and shared standards particularly valuable. BRICS members bring substantial scientific, population, and industrial diversity, but collaboration is influenced by differing regulatory systems, data policies, and research priorities. The European Union emphasizes coordinated governance, cross-border research, and responsible AI deployment. G7 economies generally combine advanced life-sciences institutions with strong expectations for cybersecurity, validation, and regulatory accountability. GCC members are building coordinated innovation and health-data capabilities, while NATO countries increasingly consider secure data infrastructure, resilience, and trusted technology supply chains alongside biomedical applications.

Country Insights: Distinct National Strengths and Deployment Conditions

Australia combines strong academic research with opportunities to apply AI across geographically distributed health and research systems. Brazil and Mexico have significant biomedical needs and research communities, with deployment influenced by infrastructure, data access, and public-private coordination. Canada, the United Kingdom, France, Germany, Italy, and Spain offer established research institutions and regulatory environments, while their priorities include interoperability, responsible use, and translation into clinical and industrial settings. The United States has broad capabilities across biomedical research, software, and venture-backed innovation, alongside demanding expectations for validation and compliance. China is advancing computational and life-sciences infrastructure at scale; Japan emphasizes high-quality research, precision, and integration with established industrial capabilities; South Korea combines strong technology and biomedical sectors. India offers extensive scientific and technical talent and is expanding digital health and biotechnology capacity. Russia maintains scientific capabilities but faces constraints related to international collaboration, access to specialized technologies, and data connectivity.

Action Priorities for Leaders Building Reliable AI Discovery Programs

Leaders should begin with clearly defined scientific decisions and measurable validation criteria rather than adopting AI tools solely for novelty. Establishing governed data foundations-including provenance, quality controls, access policies, and standardized representations-can improve reproducibility and model performance. Organizations should connect computational predictions to prospective laboratory tests, preserve audit trails, and require domain-expert review for consequential decisions. Interoperability, cybersecurity, intellectual-property management, and regulatory documentation should be designed into workflows from the outset. Finally, teams should invest in multidisciplinary capabilities spanning biology, chemistry, data science, software engineering, and responsible AI, while evaluating tools on demonstrated scientific utility and operational fit.

Research Methodology: Evidence-Led Assessment of the AI Discovery Landscape

This executive summary is structured around the supplied market scope, “Drug Discovery AI Tools,” and a qualitative synthesis of established industry and research dimensions. The assessment considers technology applications, workflow integration, data and validation requirements, regulatory and governance factors, infrastructure, skills, and regional operating conditions. Regional, group, and country observations are framed as comparative context rather than quantitative market claims. Conclusions are limited to verifiable structural insights and avoid estimates, forecasts, market shares, and company-specific assessments.

Conclusion: Responsible Integration Determines Strategic Value

Drug discovery AI tools are becoming more influential as research organizations seek to connect complex datasets with faster, better-prioritized experimentation. Their durable contribution will depend less on model sophistication alone than on reliable data, prospective validation, explainable decision processes, secure infrastructure, and effective collaboration between computational and experimental teams. Organizations that build these foundations can use AI to augment scientific judgment while maintaining the governance and evidence standards required for credible drug discovery.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Drug Discovery AI Tools Market, by Component
7.1. Introduction
7.2. Services
7.2.1. Consulting & Professional Services
7.2.2. Integration & Implementation
7.2.3. Managed Services & Support
7.3. Software
7.3.1. Integrated Suites
7.3.2. Platforms
7.3.3. Standalone Tools
8. Drug Discovery AI Tools Market, by Technology
8.1. Introduction
8.2. Computer Vision / Image Analysis
8.3. Deep Learning
8.4. Machine Learning (Traditional/Ensemble)
8.5. Natural Language Processing
8.6. Predictive Analytics / Statistical Modeling
8.7. Reinforcement Learning
9. Drug Discovery AI Tools Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Infectious Diseases
9.4. Metabolic Disorders
9.5. Neurology
9.6. Oncology
9.7. Rare Diseases
10. Drug Discovery AI Tools Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Biotechnology Companies
10.4. Contract Research Organizations (CROs)
10.5. Pharmaceutical Companies
11. Drug Discovery AI Tools Market, by Application
11.1. Introduction
11.2. ADMET Prediction & Toxicology
11.3. Biomarker Discovery & Patient Stratification
11.4. Drug Repositioning
11.5. Lead Identification & Optimization
11.6. Preclinical Testing & Simulation
11.7. Target Discovery & Validation
12. Drug Discovery AI Tools Market, by Deployment Mode
12.1. Introduction
12.2. Cloud
12.3. Hybrid
12.4. On-Premise
13. Drug Discovery AI Tools Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Drug Discovery AI Tools Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Drug Discovery AI Tools Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Absci Corporation
17.2. Atomwise, Inc.
17.3. BenevolentAI Limited
17.4. Exscientia plc
17.5. Generate Biomedicines, Inc.
17.6. Genesis Therapeutics, Inc.
17.7. Insilico Medicine, Inc.
17.8. Insitro, Inc.
17.9. Isomorphic Labs Limited
17.10. NVIDIA Corporation
17.11. Owkin, Inc.
17.12. Recursion Pharmaceuticals, Inc.
17.13. Relay Therapeutics, Inc.
17.14. Schrödinger, Inc.
17.15. XtalPi, Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Drug Discovery AI Tools Market, Years Considered for the Study
FIGURE 2. Global Drug Discovery AI Tools Market, Research Design
FIGURE 3. Global Drug Discovery AI Tools Market, Research Framework
FIGURE 4. Global Drug Discovery AI Tools Market, Data Triangulation
FIGURE 5. Global Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Drug Discovery AI Tools Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Drug Discovery AI Tools Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Drug Discovery AI Tools Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Drug Discovery AI Tools Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Drug Discovery AI Tools Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 11. Global Drug Discovery AI Tools Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Drug Discovery AI Tools Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Drug Discovery AI Tools Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Drug Discovery AI Tools Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Drug Discovery AI Tools Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Drug Discovery AI Tools Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 17. Global Drug Discovery AI Tools Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Drug Discovery AI Tools Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Drug Discovery AI Tools Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Drug Discovery AI Tools Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Drug Discovery AI Tools Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Drug Discovery AI Tools Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Drug Discovery AI Tools Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Drug Discovery AI Tools Market Segmentation & Coverage
TABLE 2. Global Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 3. Global Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Consulting & Professional Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Consulting & Professional Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Consulting & Professional Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Integration & Implementation Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Integration & Implementation Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Integration & Implementation Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Managed Services & Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Managed Services & Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Managed Services & Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Integrated Suites Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Integrated Suites Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Integrated Suites Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Standalone Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Standalone Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Standalone Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 29. Global Computer Vision / Image Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Computer Vision / Image Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Computer Vision / Image Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Deep Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Deep Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Deep Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Machine Learning (Traditional/Ensemble) Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Machine Learning (Traditional/Ensemble) Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Machine Learning (Traditional/Ensemble) Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Natural Language Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Natural Language Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Natural Language Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Predictive Analytics / Statistical Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Predictive Analytics / Statistical Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Predictive Analytics / Statistical Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Reinforcement Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Reinforcement Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Reinforcement Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 48. Global Cardiovascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Cardiovascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Cardiovascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Metabolic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Metabolic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Metabolic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Rare Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Rare Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Rare Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Contract Research Organizations (CROs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Contract Research Organizations (CROs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Contract Research Organizations (CROs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Global ADMET Prediction & Toxicology Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global ADMET Prediction & Toxicology Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global ADMET Prediction & Toxicology Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Biomarker Discovery & Patient Stratification Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Biomarker Discovery & Patient Stratification Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Biomarker Discovery & Patient Stratification Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Drug Repositioning Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Drug Repositioning Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Drug Repositioning Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Lead Identification & Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Lead Identification & Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Lead Identification & Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Preclinical Testing & Simulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Preclinical Testing & Simulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Preclinical Testing & Simulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Target Discovery & Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Target Discovery & Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Target Discovery & Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 99. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Hybrid Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Hybrid Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Hybrid Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global On-Premise Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global On-Premise Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global On-Premise Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Drug Discovery AI Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Drug Discovery AI Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 118. North America Drug Discovery AI Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. North America Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 120. North America Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 121. North America Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 122. North America Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. North America Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 124. North America Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. North America Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. North America Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 127. Latin America Drug Discovery AI Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Latin America Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 129. Latin America Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 130. Latin America Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 131. Latin America Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. Latin America Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 133. Latin America Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Latin America Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Latin America Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 136. Europe Drug Discovery AI Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Europe Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 138. Europe Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 139. Europe Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 140. Europe Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 141. Europe Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 142. Europe Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Europe Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Europe Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 145. Middle East Drug Discovery AI Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Middle East Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 147. Middle East Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 148. Middle East Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 149. Middle East Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 150. Middle East Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 151. Middle East Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Middle East Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. Middle East Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 154. Africa Drug Discovery AI Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Africa Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 156. Africa Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 157. Africa Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 158. Africa Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. Africa Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 160. Africa Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Africa Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Africa Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 163. Global Drug Discovery AI Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. ASEAN Drug Discovery AI Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. ASEAN Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 166. ASEAN Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 167. ASEAN Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 168. ASEAN Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 169. ASEAN Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 170. ASEAN Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. ASEAN Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. ASEAN Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 173. GCC Drug Discovery AI Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. GCC Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 175. GCC Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 176. GCC Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 177. GCC Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 178. GCC Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 179. GCC Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. GCC Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. GCC Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 182. European Union Drug Discovery AI Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. European Union Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 184. European Union Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 185. European Union Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 186. European Union Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 187. European Union Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 188. European Union Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. European Union Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. European Union Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 191. BRICS Drug Discovery AI Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. BRICS Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 193. BRICS Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 194. BRICS Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 195. BRICS Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. BRICS Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 197. BRICS Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. BRICS Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. BRICS Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 200. G7 Drug Discovery AI Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. G7 Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 202. G7 Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 203. G7 Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 204. G7 Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 205. G7 Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 206. G7 Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. G7 Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. G7 Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 209. NATO Drug Discovery AI Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. NATO Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 211. NATO Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 212. NATO Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 213. NATO Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 214. NATO Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 215. NATO Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. NATO Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. NATO Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 218. Global Drug Discovery AI Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 219. United States Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 220. United States Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 221. United States Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 222. United States Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 223. United States Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. United States Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 225. United States Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. United States Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. United States Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 228. Canada Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 229. Canada Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 230. Canada Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 231. Canada Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 232. Canada Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 233. Canada Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 234. Canada Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Canada Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Canada Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 237. Mexico Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 238. Mexico Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 239. Mexico Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 240. Mexico Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 241. Mexico Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. Mexico Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 243. Mexico Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. Mexico Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Mexico Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 246. Brazil Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 247. Brazil Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 248. Brazil Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 249. Brazil Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 250. Brazil Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. Brazil Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 252. Brazil Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Brazil Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. Brazil Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 255. United Kingdom Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 256. United Kingdom Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 257. United Kingdom Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 258. United Kingdom Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 259. United Kingdom Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 260. United Kingdom Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 261. United Kingdom Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. United Kingdom Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. United Kingdom Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 264. Germany Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 265. Germany Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 266. Germany Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 267. Germany Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 268. Germany Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. Germany Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 270. Germany Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. Germany Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. Germany Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 273. France Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 274. France Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 275. France Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 276. France Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 277. France Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 278. France Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 279. France Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. France Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. France Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 282. Russia Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 283. Russia Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 284. Russia Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 285. Russia Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 286. Russia Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 287. Russia Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 288. Russia Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Russia Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Russia Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 291. Italy Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 292. Italy Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 293. Italy Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 294. Italy Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 295. Italy Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 296. Italy Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 297. Italy Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. Italy Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. Italy Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 300. Spain Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 301. Spain Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 302. Spain Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 303. Spain Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 304. Spain Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 305. Spain Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 306. Spain Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. Spain Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. Spain Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 309. China Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 310. China Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 311. China Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 312. China Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 313. China Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 314. China Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 315. China Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. China Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. China Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 318. India Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 319. India Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 320. India Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 321. India Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 322. India Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 323. India Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 324. India Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 325. India Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 326. India Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 327. Japan Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 328. Japan Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 329. Japan Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 330. Japan Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 331. Japan Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 332. Japan Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 333. Japan Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. Japan Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 335. Japan Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 336. Australia Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 337. Australia Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 338. Australia Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 339. Australia Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 340. Australia Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 341. Australia Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 342. Australia Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 343. Australia Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 344. Australia Drug Discovery AI Tools Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 345. South Korea Drug Discovery AI Tools Market Size, 2017-2032 (USD Million)
TABLE 346. South Korea Drug Discovery AI Tools Market Size, by Component, 2017-2032 (USD Million)
TABLE 347. South Korea Drug Discovery AI Tools Market Size, by Services, 2017-2032 (USD Million)
TABLE 348. South Korea Drug Discovery AI Tools Market Size, by Software, 2017-2032 (USD Million)
TABLE 349. South Korea Drug Discovery AI Tools Market Size, by Technology, 2017-2032 (USD Million)
TABLE 350. South Korea Drug Discovery AI Tools Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 351. South Korea Drug Discovery AI Tools Market Size, by End User, 2017-2032 (USD Million)
TABLE 352. South Korea Drug Discovery AI Tools Market Size, by Application, 2017-2032 (USD Million)
TABLE 353. South Korea Drug Discovery AI Tools Market Size, by Deployment Mod

Companies Mentioned

  • Absci Corporation
  • Atomwise, Inc.
  • BenevolentAI Limited
  • Exscientia plc
  • Generate Biomedicines, Inc.
  • Genesis Therapeutics, Inc.
  • Insilico Medicine, Inc.
  • Insitro, Inc.
  • Isomorphic Labs Limited
  • NVIDIA Corporation
  • Owkin, Inc.
  • Recursion Pharmaceuticals, Inc.
  • Relay Therapeutics, Inc.
  • Schrödinger, Inc.
  • XtalPi, Inc.

Related Topics

Related Reports

Drug Discovery Informatics Market - Global Forecast 2026-2032 - Product Image

Drug Discovery Informatics Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
AI-Assisted Drug Discovery Software Market - Global Forecast 2026-2032 - Product Image

AI-Assisted Drug Discovery Software Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Drug Simulation Research & Development Platform Market - Global Forecast 2026-2032 - Product Image

Drug Simulation Research & Development Platform Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Biosimulation Market - Global Forecast 2026-2032 - Product Image

Biosimulation Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Structural Biology & Molecular Modeling Techniques Market - Global Forecast 2026-2032 - Product Image

Structural Biology & Molecular Modeling Techniques Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.